Map clinical and employee data before adding AI or integrations

The dashboard may need less data than the interface copies

A clinical operations dashboard needs weekly site totals. The proposed integration copies participant names, contact details and free-text notes because those fields are available in the source export. The design has expanded access without demonstrating why that information is needed.

Pharma clinical data privacy starts with the purpose of the work. The same discipline applies to employee information used in training, staffing or analytics. A technically convenient export should not become the default definition of the data the new service receives.

For India, check the applicable legal position at the time of implementation. The notified Digital Personal Data Protection (DPDP) Rules 2025 specify staged commencement, including different timing for different rule groups. Do not describe all their requirements as having commenced together. DPDP Rules 2025, rule 1.

Start with a decision and a named owner

Write a short purpose statement describing what users need to decide or perform. “Improve analytics” is too broad. “Show the study manager weekly site-level recruitment totals to identify planning discrepancies” is specific enough to challenge unnecessary fields.

Identify the business owner, source-data owner, privacy reviewer and technical operator. They have different responsibilities: the business owner explains the need, the source owner explains the data, and the privacy and legal functions assess the applicable conditions and obligations.

Record the intended users and destinations, including external suppliers. A dataset copied to an analytics warehouse and then to an AI service has more than one destination. Each transfer needs an understood purpose and approved handling arrangement.

Build a field-level map

Inspect the actual payload, not just its schema description. Free-text fields and attachments can contain information that is absent from the named columns. Logs, error traces and support tickets may also receive copies during normal operation.

Keep the map connected to implementation. A privacy assessment describing five fields is weak evidence if the deployed interface transmits twenty. Changes to payloads, destinations and purposes should trigger the relevant reassessment.

Worked example: site totals without participant identities

Consider an illustrative planning dashboard that shows weekly counts for each study site. The initial design exports participant identifiers, names, dates of birth and appointment details, then calculates counts in the reporting service.

The team reviews the purpose and determines that the intended planning decision can use totals produced within the authorised source environment. The revised interface sends the study identifier, site identifier, reporting period, defined count and reconciliation reference. It excludes participant-level fields from the dashboard flow.

The reduction needs testing. A free-text exception message might still contain a name, while very small groups or combined filters could reveal information in context. The privacy and study owners assess those risks and decide appropriate reporting restrictions rather than assuming aggregation always guarantees anonymity.

The integration team verifies sample payloads, logs, cached exports and failure notifications. A technical failure should reveal enough for authorised support to diagnose it without copying unnecessary participant information into a general incident channel.

This example illustrates purpose-led minimisation. It does not establish the legal basis for a particular study or imply that removing names alone makes a dataset anonymous.

Assess clinical and employee uses separately

Clinical information may be governed by study commitments, ethics arrangements, contracts and applicable sectoral requirements in addition to privacy law. ICH E6(R3) also addresses protection of participant-identifying information. ICH E6(R3), principle 1.6.

Employee training or scheduling information has a different purpose and context. Do not reuse a clinical-data justification for HR analytics, or copy employee health details into a shift tool merely because they exist in an HR record. Assess the particular use and the information necessary for it.

Maintain a dated applicability register covering the relevant Act provisions, rules, commencement instruments and other obligations. The MeitY DPDP publication page provides the official rules and enforcement-timeline entry. Legal owners should confirm the operational conclusions rather than relying on an undated vendor checklist.

Apply access before data reaches the user

Define role and study boundaries at the source or service layer used for retrieval. Hiding a column in the screen is insufficient if the same user can download it through an export or query it through another endpoint.

The access review guide explains how to reconcile permissions with current responsibilities. Include service accounts, supplier support and administrator access in that review. These identities can have wider reach than ordinary users.

Test a role change and removal of study access. Confirm that cached reports, saved searches and downstream datasets follow the approved access model. Historical attribution should remain available to authorised reviewers without keeping the former user's current permissions active.

Resolve retention and deletion dependencies

Map where records and copies live, including archives, backups, analytics tables and AI retrieval stores. Establish the applicable retention purpose and requirements for each category with the responsible owners. One retention period applied to every copy can either remove needed evidence or retain unnecessary data.

Define how requests and corrections are assessed across connected systems. Where retention obligations or other conditions affect deletion, route the decision to the authorised function and preserve the rationale. Do not promise instant universal deletion if the architecture cannot perform or justify it.

Test the actual process with synthetic records. Removing a source row may leave its text in an index or a generated report. The team should understand those dependencies before describing a deletion capability to users or reviewers.

Ask precise questions about AI and suppliers

For any AI service, identify what is sent in prompts, retrieved context, attachments, telemetry and support logs. Confirm the contractual and technical handling of that information, including permitted use, retention, access and location where relevant. A broad “enterprise” label does not answer these questions.

The SOP assistant guide describes access-controlled retrieval. For clinical or employee information, begin with a reduced, authorised dataset and assess whether the proposed AI function is necessary for the purpose at all.

Review changes to supplier services as part of ongoing ownership. A new logging feature, subprocessor or analytics option can alter the information path. Assign responsibility for assessing such changes rather than treating procurement approval as permanent evidence of suitability.

Verify the flow end to end

Select one integration connected to the CTMS workflow. Compare the approved field map with actual traffic, permissions and retention behaviour. Include normal processing, an error, a support investigation and a user leaving the study.

Document discrepancies and correct the implementation or approved design through the relevant process. Useful measures include unnecessary fields removed, access mismatches resolved and untracked copies identified. These are operating indicators, not a certificate of legal compliance.

Summary and next actions

Privacy work becomes actionable when the organisation can explain why each field moves, who can use it and what happens throughout its lifecycle. That evidence should precede additional integrations or AI access.

• Map one proposed data flow from its business purpose through every destination and supporting log.
• Confirm applicable obligations and commencement dates with the legal and privacy owners.
• Reduce the payload and test access, correction, retention and deletion dependencies using synthetic records.
• Assign ongoing ownership for supplier changes, new purposes and differences between the approved map and deployed behaviour.